Preparing For The New Biomanufacturing Frontier: A Fireside Chat With FluGen's Andy Skibo
Source: Life Science Leader
At the Generis 2020 American Biomanufacturing Summit (July 21 – 23), Andy Skibo, chief manufacturing officer for FluGen, discusses the challenges around developing and delivering a COVID-19 vaccine on a significantly shortened timeframe, plus other opportunities for improving biomanufacturing and its supply chain to support future therapies.